Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance.

Liu J, Yu M, Zhou C, Yang S, Ning X, Zheng J.

J Am Chem Soc. 2013 Apr 3;135(13):4978-81. doi: 10.1021/ja401612x.

2.

Mixed-charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation.

Liu X, Li H, Chen Y, Jin Q, Ren K, Ji J.

Adv Healthc Mater. 2014 Sep;3(9):1439-47. doi: 10.1002/adhm.201300617.

PMID:
24550205
3.

Enhanced retention and cellular uptake of nanoparticles in tumors by controlling their aggregation behavior.

Liu X, Chen Y, Li H, Huang N, Jin Q, Ren K, Ji J.

ACS Nano. 2013 Jul 23;7(7):6244-57. doi: 10.1021/nn402201w.

PMID:
23799860
4.

Labeling Monomeric Insulin with Renal-Clearable Luminescent Gold Nanoparticles.

Vinluan RD 3rd, Yu M, Gannaway M, Sullins J, Xu J, Zheng J.

Bioconjug Chem. 2015 Dec 16;26(12):2435-41. doi: 10.1021/acs.bioconjchem.5b00490.

PMID:
26465678
5.

Biocompatible glycol chitosan-coated gold nanoparticles for tumor-targeting CT imaging.

Sun IC, Na JH, Jeong SY, Kim DE, Kwon IC, Choi K, Ahn CH, Kim K.

Pharm Res. 2014 Jun;31(6):1418-25. doi: 10.1007/s11095-013-1142-0.

PMID:
23934255
6.

Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.

Elbialy NS, Fathy MM, Khalil WM.

Int J Pharm. 2015 Jul 25;490(1-2):190-9. doi: 10.1016/j.ijpharm.2015.05.032.

PMID:
25997662
7.

Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates.

Cheng Y, Meyers JD, Broome AM, Kenney ME, Basilion JP, Burda C.

J Am Chem Soc. 2011 Mar 2;133(8):2583-91. doi: 10.1021/ja108846h.

8.
9.

Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency.

Sykes EA, Chen J, Zheng G, Chan WC.

ACS Nano. 2014 Jun 24;8(6):5696-706. doi: 10.1021/nn500299p.

PMID:
24821383
10.

Fluorescence-tagged gold nanoparticles for rapidly characterizing the size-dependent biodistribution in tumor models.

Chou LY, Chan WC.

Adv Healthc Mater. 2012 Nov;1(6):714-21. doi: 10.1002/adhm.201200084.

PMID:
23184822
11.

Regiospecific Hetero-Assembly of DNA-Functionalized Plasmonic Upconversion Superstructures.

Li LL, Lu Y.

J Am Chem Soc. 2015 Apr 29;137(16):5272-5. doi: 10.1021/jacs.5b01092.

12.

Synthesis of a smart nanovehicle for targeting liver.

De A, Mishra S, Garg S, Mozumdar S.

Methods Mol Biol. 2014;1141:211-32. doi: 10.1007/978-1-4939-0363-4_14.

PMID:
24567142
13.

Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis.

Peiris PM, Deb P, Doolittle E, Doron G, Goldberg A, Govender P, Shah S, Rao S, Carbone S, Cotey T, Sylvestre M, Singh S, Schiemann WP, Lee Z, Karathanasis E.

J Pharm Sci. 2015 Aug;104(8):2600-10. doi: 10.1002/jps.24518.

14.

Detection of Phosphatidylcholine-Coated Gold Nanoparticles in Orthotopic Pancreatic Adenocarcinoma using Hyperspectral Imaging.

England CG, Huang JS, James KT, Zhang G, Gobin AM, Frieboes HB.

PLoS One. 2015 Jun 5;10(6):e0129172. doi: 10.1371/journal.pone.0129172.

15.

Renal clearance and degradation of glutathione-coated copper nanoparticles.

Yang S, Sun S, Zhou C, Hao G, Liu J, Ramezani S, Yu M, Sun X, Zheng J.

Bioconjug Chem. 2015 Mar 18;26(3):511-9. doi: 10.1021/acs.bioconjchem.5b00003.

16.

Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy.

Chen H, Li S, Li B, Ren X, Li S, Mahounga DM, Cui S, Gu Y, Achilefu S.

Nanoscale. 2012 Sep 28;4(19):6050-64. doi: 10.1039/c2nr31616a.

PMID:
22930451
17.

Glutathione-triggered luminescent silver nanoparticle: A urinary clearable nanoparticle for potential clinical practice.

Yang S, Zhou C, Cai XJ.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:751-5. doi: 10.1016/j.colsurfb.2015.06.069.

PMID:
26342320
18.

Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.

Rahme K, Guo J, Holmes JD, O'Driscoll CM.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:604-12. doi: 10.1016/j.colsurfb.2015.08.032.

PMID:
26322474
19.

Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery.

Hossen MN, Kajimoto K, Akita H, Hyodo M, Harashima H.

J Control Release. 2012 Oct 28;163(2):101-10. doi: 10.1016/j.jconrel.2012.09.002.

PMID:
22982237
20.

The application of gold nanoparticles as a promising therapeutic approach in breast and ovarian cancer.

Kafshdooz L, Kafshdooz T, Razban Z, Akbarzadeh A.

Artif Cells Nanomed Biotechnol. 2016 Aug;44(5):1222-7. doi: 10.3109/21691401.2015.1029625. Review.

PMID:
25871281
Items per page

Supplemental Content

Support Center